Portage Biotech Inc.

NAS: PRTG

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Portage Biotech Inc.

After Hours

 --Quotes are delayed by 20 min

Jun 24, 2022, 5:17 p.m.

PRTG
/zigman2/quotes/205701577/composite

$

6.70

Change

0.00 0.00%

Volume

Volume 86,655

Quotes are delayed by 20 min

/zigman2/quotes/205701577/composite

Previous close

$ 6.89

$ 6.70

Change

-0.19 -2.76%

Day low

Day high

$6.01

$7.51

Open

52 week low

52 week high

$4.62

$25.70

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Portage Biotech Inc.

View Ratios
Fiscal year is April-March. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -----
Depreciation -----
Amortization of Intangibles -----
Gross Income -----
20172018201920202021 5-year trend
SG&A Expense 35.49M2.23M2.76M5.98M12.44M
Research & Development 32.45M561,000762,0004.11M7.31M
Other SG&A 3.04M1.67M2M1.87M5.13M
Other Operating Expense -----
Unusual Expense ---9,0002.27M
EBIT after Unusual Expense ---(9,000)(14.71M)
Non Operating Income/Expense -126M(691,000)6,000484,000
Non-Operating Interest Income --111,00011,000-
Equity in Affiliates (Pretax) -----
Interest Expense 552,42232,00088,000557,000177,000
Gross Interest Expense 552,42232,00088,000557,000177,000
Interest Capitalized -----
Pretax Income (36.04M)123.74M(3.43M)(6.53M)(14.4M)
Income Tax ---740,0002.3M
Income Tax - Current Domestic ---740,0002.3M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates 35.4M-(162,000)18,000(490,000)
Other After Tax Income (Expense) -----
Consolidated Net Income (641,274)123.74M(3.59M)(7.25M)(17.19M)
Minority Interest Expense (16.94M)-(959,000)(1.92M)(1.36M)
Net Income 16.3M123.74M(2.64M)(5.33M)(15.83M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 16.3M123.74M(2.64M)(5.33M)(15.83M)
Preferred Dividends -----
Net Income Available to Common 16.3M123.74M(2.64M)(5.33M)(15.83M)
EPS (Basic) 6.0046.00(0.55)(0.49)(1.35)
Basic Shares Outstanding 2.54M2.68M4.82M10.95M11.73M
EPS (Diluted) 6.0046.00(0.55)(0.49)(1.35)
Diluted Shares Outstanding 2.72M2.7M4.82M10.95M11.73M
EBITDA (35.49M)(2.23M)(2.76M)(5.98M)(12.44M)
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.